Ausgabe 1/1997
Inhalt (8 Artikel)
Antiestrogens: Mechanisms of action and resistance in breast cancer
Benita S. Katzenellenbogen, Monica M. Montano, Kirk Ekena, Mary E. Herman, Eileen M. McInerney
Histopathology grading in small brast cancers ≤ 10mm – results from an area with mammography screening
Lars-Gunnar Arnesson, Thomas Hatschek, Staffan Smeds, Otto Gröntoft
Mechanism of action of a tyrphostin, 3,4-dihydroxy-α-cyanothiocinnamamide, in breast cancer cell growth inhibition involves the suppression of cyclin B1 and the functional activity of cyclin B1/p34cdc2 complex
Carol A. Faaland, Sreedevi Adhikarakunnathu, Thresia Thomas, T.J. Thomas
Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase
William E. Burak Jr., Anne L. Quinn, William B. Farrar, Robert W. Brueggemeier
Cytological evaluation of biological prognostic markers from primary breast carcinomas
A. Makris, D.C. Allred, T.J. Powles, M. Dowsett, I.N. Fernando, P.A. Trott, S.E. Ashley, M.G. Ormerod, J.C. Titley, C.K. Osborne
Trends in the incidence rate and risk factors for breast cancer in Japan
Chisato Nagata, Norito Kawakami, Hiroyuki Shimizu
Urinary steroids at time of surgery in postmenopausal women with breast cancer
Susan Juricskay, István Szabó, Károly Kett